Scottsdale, AZ, United States of America

Manzer Durrani

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Michigan. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manzer Durrani. Retrieved from https://idiyas.com/inventor/manzer-durrani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manzer Durrani: Innovator in Benzodiazepine Compounds

Introduction

Manzer Durrani is a notable inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel chemical compounds. His work focuses on therapeutic applications that address various medical conditions.

Latest Patents

Durrani holds a patent for "Soluble 1,4 benzodiazepine compounds and stable salts thereof." This invention relates to new benzodiazepine derivatives and their therapeutic uses. The compounds are designed to treat conditions associated with faulty regulation of programmed cell death, autoimmunity, inflammation, and hyperproliferation.

Career Highlights

Manzer Durrani is affiliated with the University of Michigan, where he continues to advance his research in chemical compounds. His innovative work has the potential to impact various therapeutic areas significantly.

Collaborations

Durrani has collaborated with esteemed colleagues, including William Bert Geiss and David John Fairfax. Their combined expertise enhances the research and development of therapeutic agents.

Conclusion

Manzer Durrani's contributions to the field of benzodiazepine compounds exemplify the importance of innovation in medical research. His work not only advances scientific knowledge but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…